Overview: Immunoglobulin G CSF TestIntroduction: The Immunoglobulin G CSF Test measures IgG in cerebrospinal fluid (CSF) to diagnose neurological disorders like multiple sclerosis, causing weakness or numbness. Aligned with 2023 AAN guidelines, it uses immunoassays for high specificity, supporting neurological screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected neurological conditions.
Other Names: IgG CSF Assay, CSF Immunoglobulin Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: CSF IgG testing began in the 1970s with multiple sclerosis research. Immunoassay-based methods improved in the 1990s, enhancing diagnostic precision.
Purpose: Measures IgG in CSF to diagnose neurological disorders, guides treatment, and evaluates patients with weakness or numbness.
Test Parameters: 1. Immunoglobulin IgG (CSF)
Pretest Condition: No fasting required. Collect CSF via lumbar puncture. Report history of neurological symptoms, multiple sclerosis, or infections.
Specimen: 1-2 mL CSF (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document weakness, numbness, visual disturbances, or history of neurological disorders. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, neurological implications, and risks of lumbar puncture.
Procedural Considerations: Uses immunoassays to measure IgG in CSF, often with oligoclonal band analysis. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for neurological assessment.
Factors Affecting Result Accuracy: Improper sample collection, contamination, or blood in CSF can affect results. Recent infections may influence IgG levels.
Clinical Significance: Elevated IgG or oligoclonal bands suggest multiple sclerosis or other neurological disorders, guiding immunosuppressive therapy. Normal levels may require further testing.
Specialist Consultation: Consult a neurologist for result interpretation and treatment planning.
Additional Supporting Tests: CSF oligoclonal bands, MRI, or evoked potentials to assess neurological disorders.
Test Limitations: Not specific to multiple sclerosis; other neurological conditions may elevate IgG. Clinical correlation is needed.
References: AAN Multiple Sclerosis Guidelines, 2023; Neurology, Thompson AJ, 2022.
